Moreover, differential OXT agonism at AVPR1a could have important implications for understanding the therapeutic potential of nonapeptide treatments in alleviating symptoms associated with neurodevelopmental disorders such as autism spectrum disorders (ASD). Here, OXT is linked to neurodevelopmental disorder.